ATE10838T1 - 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung. - Google Patents
4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung.Info
- Publication number
- ATE10838T1 ATE10838T1 AT81101322T AT81101322T ATE10838T1 AT E10838 T1 ATE10838 T1 AT E10838T1 AT 81101322 T AT81101322 T AT 81101322T AT 81101322 T AT81101322 T AT 81101322T AT E10838 T1 ATE10838 T1 AT E10838T1
- Authority
- AT
- Austria
- Prior art keywords
- processes
- antibiotics
- substituted
- manufacture
- production
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title abstract 2
- 229940088710 antibiotic agent Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 2
- -1 4-SUBSTITUTED 2-OXOAZETIDINE COMPOUNDS Chemical class 0.000 title 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000004442 acylamino group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002462 isocyano group Chemical group *[N+]#[C-] 0.000 abstract 1
- 125000000962 organic group Chemical group 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/04—Preparation by forming the ring or condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/568—Four-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8006842 | 1980-02-28 | ||
EP81101322A EP0035689B1 (de) | 1980-02-28 | 1981-02-24 | 4-Substituierte 2-Oxoazetidin-Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung zur Antibiotika-Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE10838T1 true ATE10838T1 (de) | 1985-01-15 |
Family
ID=10511761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT81101322T ATE10838T1 (de) | 1980-02-28 | 1981-02-24 | 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung. |
Country Status (5)
Country | Link |
---|---|
US (2) | US4383945A (de) |
EP (1) | EP0035689B1 (de) |
JP (1) | JPS56131565A (de) |
AT (1) | ATE10838T1 (de) |
DE (1) | DE3167774D1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE52147B1 (en) * | 1980-03-27 | 1987-07-08 | Merck & Co Inc | 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation |
JPS58167564A (ja) * | 1982-03-29 | 1983-10-03 | Nippon Kayaku Co Ltd | 4−(3−アルコキシカルボニル−2−オキソプロビル)−2−アゼチジノン誘導体の製造法 |
JPS58192866A (ja) * | 1982-04-30 | 1983-11-10 | Kanegafuchi Chem Ind Co Ltd | 2―アゼチジノン誘導体 |
US4771135A (en) * | 1984-05-22 | 1988-09-13 | Eli Lilly And Company | Process for carbon-carbon bond formation at the C-4 position of 3-acylaminoazetidinones and products and starting materials therefor |
CA1249279A (en) * | 1984-05-22 | 1989-01-24 | Larry C. Blaszczak | Process for carbon-carbon bond formation at the c-4 position of 3-acylaminoazetidinones |
US4918185A (en) * | 1984-05-22 | 1990-04-17 | Eli Lilly And Company | Process for carbon-carbon bond formation at the C-4 position of 3-acylaminoazetidinones and products and starting materials therefor |
DE3509769A1 (de) * | 1985-03-19 | 1986-09-25 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von carbapenemzwischenprodukten |
DE3678275D1 (de) * | 1986-01-08 | 1991-04-25 | Merck & Co Inc | Verfahren zur herstellung chiraler 1-beta-methylcarbapenem-zwischenverbindungen. |
US4816578A (en) * | 1986-06-24 | 1989-03-28 | Merck & Co., Inc. | Process for the stereocontrolled silyloxyethylation of azetidinones |
US4960879A (en) * | 1988-03-23 | 1990-10-02 | Shionogi & Co., Ltd. | Process for carbapenem intermediates |
US4876365A (en) * | 1988-12-05 | 1989-10-24 | Schering Corporation | Intermediate compounds for preparing penems and carbapenems |
US5239069A (en) * | 1990-05-14 | 1993-08-24 | Eli Lilly And Company | Amino protecting group |
US7772392B2 (en) * | 2005-05-06 | 2010-08-10 | Allergan, Inc. | Therapeutic substituted β-lactams |
WO2008144623A1 (en) * | 2007-05-23 | 2008-11-27 | Allergan, Inc. | Cyclic lactams for the treatment of glaucoma or elevated intraocular pressure |
CN111675641B (zh) * | 2020-06-04 | 2023-09-08 | 宁夏农林科学院农业资源与环境研究所(宁夏土壤与植物营养重点实验室) | 单环β-内酰胺类化合物、单环内酰胺类化合物盐及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK523676A (da) * | 1975-11-21 | 1977-05-22 | Merck & Co Inc | Fremgangsmade til fremstilling af n-alkylerede derivater af thienamycin |
US4115383A (en) * | 1976-02-23 | 1978-09-19 | Eli Lilly And Company | Alkoxycarbonyl-ethylthio-azetidinones and process for their preparation |
US4187221A (en) * | 1976-12-31 | 1980-02-05 | Connlab Holdings Limited | Process for preparing azetidinones |
GB1584762A (en) * | 1977-04-01 | 1981-02-18 | Beecham Group Ltd | Azabicycloheptenes |
AU4061378A (en) * | 1977-10-19 | 1980-04-17 | Merck & Co., Inc. | 1-azabicyclo (3.2.0) hept-2-enes |
EP0005507A1 (de) * | 1978-05-18 | 1979-11-28 | Ciba-Geigy Ag | Fragmentierungsverfahren von 3-(2-Hydroxyimino-acetylamino)-2-oxo-azetidin-Verbindungen und die erhaltenen Verbindungen |
US4174316A (en) * | 1978-08-14 | 1979-11-13 | Merck & Co., Inc. | 4-Iodomethylazetidin-2-one |
US4273709A (en) * | 1979-07-23 | 1981-06-16 | Merck & Co., Inc. | Process for the preparation of thienamycin and intermediates |
JPS57116072A (en) * | 1981-01-12 | 1982-07-19 | Takeda Chem Ind Ltd | Beta-lactam compound and its preparation |
-
1981
- 1981-02-24 DE DE8181101322T patent/DE3167774D1/de not_active Expired
- 1981-02-24 EP EP81101322A patent/EP0035689B1/de not_active Expired
- 1981-02-24 AT AT81101322T patent/ATE10838T1/de not_active IP Right Cessation
- 1981-02-27 JP JP2913681A patent/JPS56131565A/ja active Granted
- 1981-08-27 US US06/296,840 patent/US4383945A/en not_active Expired - Fee Related
-
1982
- 1982-08-27 US US06/412,263 patent/US4539152A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US4539152A (en) | 1985-09-03 |
US4383945A (en) | 1983-05-17 |
DE3167774D1 (en) | 1985-01-31 |
EP0035689A1 (de) | 1981-09-16 |
JPS56131565A (en) | 1981-10-15 |
JPH023781B2 (de) | 1990-01-24 |
EP0035689B1 (de) | 1984-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE10838T1 (de) | 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung. | |
ATE206422T1 (de) | Verfahren zur herstellung von aryl-piperazinyl- heterocyclischen derivaten | |
ATE113281T1 (de) | Pyrazol-derivate, verfahren zu deren herstellung und anwendung. | |
ES518227A0 (es) | Procedimiento para preparar nuevos compuestos de cefem. | |
NO844139L (no) | Nye 1-substituerte-5-hydroksymetyl-2-merkapto-imidazol-derivater og fremgangsmaate for fremstilling derav | |
ES543153A0 (es) | Metodo de preparar derivados de b-carbolin-3-oxadiazolilo | |
ATE31414T1 (de) | 8-substituierte pyrrolizidin-derivate und deren verwendung. | |
ATE2324T1 (de) | Triazolyl-alken-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide. | |
PT73841A (en) | Process for preparing novel guanidine derivatives | |
DE3866148D1 (de) | Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten. | |
ATE31928T1 (de) | Acylamino-4-aza-1-adamantane, verfahren zu ihrer herstellung und ihre anwendung in der therapeutik. | |
ES532098A0 (es) | Un procedimiento para preparar derivados sustituidos en posicion 1 de azetidin-3-ol | |
ES2068663T3 (es) | Procedimiento para la preparacion de compuestos de piridina sustituidos con halogenosulfonilo. | |
ATE157971T1 (de) | Verfahren zur herstellung von aminotriazin- derivaten | |
FR2485539B1 (de) | ||
ES8307766A1 (es) | Procedimiento para la preparacion de derivados de azolil-penteno. | |
SE8005127L (sv) | Sett att framstella 15-hydroxiimino-e-homoeburnanderivat | |
ATE10370T1 (de) | Benzothiazinderivate, verfahren zu ihrer herstellung und ihre verwendung. | |
ES532507A0 (es) | Un metodo de preparar espiro (indolo (1, 7-ab) (1, 5)-benzodiazepin-2, 4'-piperidinas) | |
ATE17851T1 (de) | Imidazolylkarbonsaeure, deren derivate und herstellung. | |
ATE29253T1 (de) | Verfahren zur herstellung von 4-chinolinonen. | |
DK566181A (da) | Fremgangsmaade til fremstilling af n-pyrrolylpyridazinaminderivater | |
ES8302712A1 (es) | Un nuevo procedimiento de preparacion de imidazobenzodiazepinas. | |
DK452684D0 (da) | Fremgangsmaade til fremstilling af quinolin-4-oner | |
ATE455T1 (de) | Verfahren zur herstellung von carbazolen und ein zwischenprodukt hierfuer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |